🧾 What This Document Is

This is Caring Brands' (CABR) 10-K Annual Report for the year ended December 31, 2025. Think of it as a detailed annual check-up that public companies must file with the SEC. It tells investors what the company does, how it performed, and what risks it faces.

👉 In simple terms: This filing gives us a snapshot of a very small, newly public company trying to launch skincare and hair care products, but it's facing big challenges like a severe lack of money and a highly competitive market.

🏢 What The Company Does

Caring Brands, Inc. was formed in 2024 by separating from another company called Safety Shot. Its core business is developing and selling over-the-counter (OTC) skincare and hair care products.

Key Products:
- Photocil: A topical treatment for psoriasis and vitiligo that uses light to target skin conditions. It's registered as a cosmetic/OTC product.
- Hair Enzyme Booster (JW-700): A product designed to improve the effectiveness of minoxidil (a common hair growth treatment). It's sold as a cosmetic in India and on Amazon in the U.S.
Business Model: The company relies heavily on licensing agreements and strategic partners to manufacture, market, and sell its products in different regions (like India). It has only three full-time employees, including its CEO.
Industry Context: It operates in the crowded and competitive consumer skincare and hair growth market, facing giants with far more resources.

👉 In simple terms: Caring Brands is a tiny startup with a couple of product ideas, trying to use partnerships to compete against huge, established beauty and pharmaceutical companies.

💰 Financial Highlights

The financial picture is concerning and highlights the company's early, pre-revenue stage.

Net Losses: The company reported significant net losses for the year. While the specific numbers aren't in the provided text, the extensive "Risk Factors" section repeatedly warns about its financial condition.
Going Concern Warning: This is a critical red flag. The auditors and management explicitly state there is "substantial doubt about our ability to continue as a going concern." They don't have enough money to fund operations long-term.
Capital Needs: The company states it must raise additional capital through debt or equity to survive, but there's no guarantee it can do so on favorable terms—or at all.
Market Value: As of June 30, 2025, the market value of its stock held by non-affiliates was a mere $3.96 million.
Shares Outstanding: As of March 30, 2026, there were 12,341,506 shares of common stock outstanding.

👉 Why it matters: These are the numbers that keep executives and investors up at night. The "going concern" warning means the company's survival is genuinely in question.

🚀 Key Moves

The filing details several crucial actions taken during and after the fiscal year.

Separation from Safety Shot: The company was officially separated and began operating independently on September 25, 2024. This is a major structural change.
Product Launches: The Hair Enzyme Booster was launched on Amazon (Oct 2024) and a partner's e-commerce platform (Dec 2024), though sales have been "minimal."
New Licensing & Financing Deals: After the fiscal year ended (in early 2026), the company entered into several new agreements for consulting, financing, and licenses. This shows it's scrambling for partnerships and cash.

👉 Why it matters: These moves show a company trying to build a business from the ground up while constantly searching for the money and partnerships to keep the lights on.

📦 Financial Position & Cash Flow

While detailed financial statements aren't provided, the filing describes a precarious situation.

Cash is King (and Scarce): The entire "Risk Factors" section screams about a lack of capital. The company has limited operating history and has funded itself through private placements and debt.
Reliance on External Funding: Survival depends on its ability to access "credit and capital markets," which it has not done before as an independent public company.
Dilution Risk: Raising the necessary cash will likely mean issuing more stock, which dilutes (reduces the value of) existing shareholders' stakes.

👉 Why it matters: This isn't about managing profits; it's about a basic survival challenge. The company is burning cash and needs to find more just to operate.

🔮 What's Next (Strategic Direction)

The company's path forward is focused on basic execution and survival.

Commercialize Products: Drive sales of its existing products, mainly the Hair Enzyme Booster on Amazon.
Leverage Partnerships: Rely on licensees and distributors in markets like India to handle manufacturing and sales.
Raise Capital: This is the most critical and immediate task. The entire strategy depends on successfully obtaining more funding.
Manage Regulatory Compliance: Continue navigating the complex rules for selling OTC and cosmetic products in the U.S. and abroad.

👉 Why it matters: The "strategy" is less about ambitious growth and more about securing the basic resources needed to become a functioning business.

⚖️ Big Picture: Strengths (👍) and Risks (⚠️)

👍 Potential Strengths:
- Niche Products: Products like Photocil and the Hair Enzyme Booster have unique proposed mechanisms of action.
- Partnership Model: Using licensees in key markets (like India) allows it to operate with minimal internal staff and infrastructure.
- Early-Mover in Hemp-Based Skincare: Mentions a focus on this growing category.
⚠️ Overwhelming Risks:
- Going Concern: The threat of running out of money and ceasing operations is the #1 risk.
- Intense Competition: Faces well-funded pharmaceutical, biotech, and consumer product giants.
- Regulatory Hurdles: Must constantly comply with FDA, FTC, and international rules, with failure risking recalls or penalties.
- Key Person Dependency: Entirely reliant on a few executives (CEO Dr. Glynn Wilson, Chairman Brian S. John).
- Small Size & New Status: A newly public company with no track record, minimal employees, and strained resources.
- Market & Stock Volatility: Its stock is subject to extreme price swings and may be classified as a "penny stock," making it hard to trade.

🧠 The Analogy

Caring Brands is like a food truck trying to launch a new gourmet recipe at a festival, but it's parked right next to established burger chains and pizza giants. The truck has a great recipe idea, but its gas tank is nearly empty, it has a skeleton crew, and it's hoping festival attendees will ignore the big names to try its unknown food—all while praying a sponsor will show up with fuel money before the festival ends.

📇 Key Contacts & People

Dr. Glynn Wilson: Chief Executive Officer
Mr. Brian John: Chairman of the Board
Paul Jones: Operations Manager (mentioned in "Employees")
Company Address: 130 S Indian River Dr. Suite 202 pbm# 1232, Fort Pierce, FL 34950
Phone: 561-896-7616

🧩 Final Takeaway

Caring Brands is an early-stage, cash-strapped company with interesting product ideas but faces monumental challenges. Its immediate future hinges almost entirely on its ability to raise new funding while navigating fierce competition and regulatory demands, all under the shadow of a "going concern" warning that casts serious doubt on its long-term viability.

Caring Brands, Inc. — 10-K Filing